These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9255199)

  • 21. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
    Transplantation; 2012 Jan; 93(1):73-81. PubMed ID: 22129761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH
    Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan.
    Hsu CT; Chang MH; Ho MC; Chang HH; Lu MY; Jou ST; Ni YH; Chen HL; Hsu HY; Wu JF
    J Formos Med Assoc; 2019 Nov; 118(11):1537-1545. PubMed ID: 30630698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
    McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
    Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C.
    McLaughlin K; Wajstaub S; Marotta P; Adams P; Grant DR; Wall WJ; Jevnikar AM; Rizkalla KS
    Liver Transpl; 2000 Sep; 6(5):570-4. PubMed ID: 10980055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
    Kim RD; Fujikawa T; Mizuno S; Schwartz JJ; Sorensen JB; Hemming AW; Fujita S
    Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):559-65. PubMed ID: 21555941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level.
    Eshraghian A; Imanieh MH; Dehghani SM; Nikeghbalian S; Shamsaeefar A; Barshans F; Kazemi K; Geramizadeh B; Malek-Hosseini SA
    World J Gastroenterol; 2017 Feb; 23(7):1224-1232. PubMed ID: 28275302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients.
    Berney T; Delis S; Kato T; Nishida S; Mittal NK; Madariaga J; Levi D; Nery JR; Cirocco RE; Gelman B; Ruiz P; Tzakis AG
    Transplantation; 2002 Oct; 74(7):1000-6. PubMed ID: 12394845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein-Barr virus.
    Hierro L; Díez-Dorado R; Díaz C; De la Vega A; Frauca E; Camarena C; Muñoz-Bartolo G; González de Zárate A; López Santamaría M; Jara P
    Liver Transpl; 2008 Aug; 14(8):1185-93. PubMed ID: 18668670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One hundred children treated with tacrolimus after primary orthotopic liver transplantation.
    McDiarmid S; Goss J; Seu P; Shackleton C; Vargas J; Ament M; Busuttil R
    Transplant Proc; 1998 Jun; 30(4):1397-8. PubMed ID: 9636564
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
    Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
    Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
    Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival after post-transplant lymphoproliferative disease in children.
    Nathanson S; Debray D; Delarue A; Deschênes G
    Pediatr Nephrol; 2002 Aug; 17(8):668-72. PubMed ID: 12185479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
    Preiksaitis JK; Diaz-Mitoma F; Mirzayans F; Roberts S; Tyrrell DL
    J Infect Dis; 1992 Nov; 166(5):986-94. PubMed ID: 1328412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus.
    Fridell JA; Jain A; Reyes J; Biederman R; Green M; Sindhi R; Mazariegos GV
    Transplantation; 2002 Dec; 74(12):1721-4. PubMed ID: 12499888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center.
    Quintini C; Kato T; Gaynor JJ; Ueno T; Selvaggi G; Gordon P; McLaughlin G; Tompson J; Ruiz P; Tzakis A
    Transplant Proc; 2006; 38(6):1755-8. PubMed ID: 16908272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.
    Cox KL; Lawrence-Miyasaki LS; Garcia-Kennedy R; Lennette ET; Martinez OM; Krams SM; Berquist WE; So SK; Esquivel CO
    Transplantation; 1995 Feb; 59(4):524-9. PubMed ID: 7533344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.
    Mañez R; Breinig MC; Linden P; Wilson J; Torre-Cisneros J; Kusne S; Dummer S; Ho M
    J Infect Dis; 1997 Dec; 176(6):1462-7. PubMed ID: 9395355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
    Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
    Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.